What happens when GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro collide with menopause, hormones, and metabolism?
In this eye-opening episode, Esther Blum breaks down the science behind GLP-1 medications for menopausal women — and explains why hormone replacement therapy (HRT), protein intake, and strength training may be the missing links to sustainable fat loss and metabolic health.
You’ll learn:
How GLP-1 medications actually work
Why menopause is a metabolic event — not just a hormonal one
The hidden muscle loss risk associated with Ozempic and similar drugs
Why estrogen, progesterone, and testosterone matter for body composition
How HRT may improve GLP-1 weight loss results by up to 15%
The connection between insulin resistance, sleep, cortisol, and menopause belly fat
Why strength training and protein are non-negotiable during midlife weight loss
If you’re navigating perimenopause, menopause, insulin resistance, or stubborn weight gain, this episode delivers practical strategies and powerful insights to help you protect your metabolism while optimizing your health.
Podden och tillhörande omslagsbild på den här sidan tillhör
Esther Blum. Innehållet i podden är skapat av Esther Blum och inte av,
eller tillsammans med, Poddtoppen.
